Abstract Objective To explore the effect of SIRT1 gene silencing on the radiosensitivity of diffuse large B-cell lymphoma (DLBCL) cells. Methods Immunohistochemistry was used to measure the protein expression of SIRT1 in DLBCL tissues. Western blot was used to measure the expression of SIRT1 in DLBCL cell lines (OCI-Ly3, SU-DHL-2, and SU-DHL-4) and the immortalized B cell line HMy2.CIR. After SU-DHL-4 cells were transfected with si-SIRT1 and si-NC using Lipofectamine 2000, the expression of SIRT1 was determined by Western blot. MTT assay and colony-forming assay were used to assess the cell growth and colony formation ability of SU-DHL-4 cells treated with radiation. The group t-test or univariate analysis of variance was used for comparison between groups. Results The expression rate of SIRT1 in DLBCL tissues was 72.6%(103/140), which was significantly higher than that in reactive lymphoid hyperplasia (RLH) tissues (26.5%, 8/25)(P=0.001). The SIRT1 expression was significantly higher in DLBCL cells than in HMy2.CIR cells (P=0.020). After SIRT1 gene silencing by si-SIRT1, the expression of SIRT1 was significantly reduced in SU-DHL-4 cells (P=0.008). Besides, SIRT1 gene silencing significantly reduced the growth rate and colony formation ability of SU-DHL-4 cells treated with radiation (P=0.030). Conclusions SIRT1 gene silencing enhances the radiosensitivity of DLBCL cells, providing a novel target for the radiotherapy of DLBCL.
Kang Yixin,Gao Shegan,Guo Yanzhen et al. Effect of SIRT1 gene silencing on radiosensitivity of diffuse large B-cell lymphoma cells[J]. Chinese Journal of Radiation Oncology, 2017, 26(6): 687-690.
Kang Yixin,Gao Shegan,Guo Yanzhen et al. Effect of SIRT1 gene silencing on radiosensitivity of diffuse large B-cell lymphoma cells[J]. Chinese Journal of Radiation Oncology, 2017, 26(6): 687-690.
[1] Hida Y,Kubo Y,Murao K,et al. Strong expression of a longevity-related protein,SIRT1,in Bowen’s disease[J].Arch Dermatol Res,2007,299(2):103-106.DOI:10.1007/s00403-006-0725-6. [2] Hori YS,Kuno A,Hosoda R,et al. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress[J/OL].PLoS One 2013,8(9):e73875.DOI:10.1371/journal.pone.0073875. [3] Zhang G,Liu Z,Qin S,et al. Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer[J].Eur J Gynaecol Oncol,2015,36(6):629-632. [4] Gorenne I,Kumar S,Gray K,et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis[J].Circulation,2013,127(3):386-396.DOI:10.1161/CIRCULATIONAHA.112.124404. [5] Hosry J,Mahale P,Turturro F,et al. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma[J].Int J Cancer,2016,139(11):2519-2528.DOI:10.1002/ijc.30372. [6] Chapuy B,Cheng H,Watahiki A,et al. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease[J].Blood,2016,127(18):2203-2213.DOI:10.1182/blood-2015-09-672352. [7] 伍钢.放射治疗在恶性淋巴瘤治疗中的地位[J].中华肿瘤防治杂志,2009(16):1201-1205. Wu G.The role of radiotherapy in the treatment of malignant lymphoma[J].Chin J Cancer Prevent Treat,2009(16):1201-1205. [8] Peng L,Yuan Z,Li Y,et al. Ubiquitinated sirtuin 1(SIRT1) function is modulated during DNA damage-induced cell death and survival[J].J Biol Chem,2015,290(14):8904-8912.DOI:10.1074/jbc. M114.612796. [9] Colak Y,Ozturk O,Senates E,et al. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease[J].Med Sci Mon Bas Res,2011,17(5):HY5-HY9. [11] Xie Y,Zhang J,Ye S,et al. SIRT1 regulates radiosensitivity of hepatoma cells differently under normoxic and hypoxic conditions[J].Cancer Sci,2012,103(7):1238-1244.DOI:10.1111/j.1349-7006.2012.02285.x. [11] Chang CJ,Hsu CC,Yung MC,et al. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SIRT1 expression[J].Biochem Biophys Res Commun,2009,380(2):236-242.DOI:10.1016/j.bbrc.2009.01.040. [12] Cao B,Shi Q,Wang W.Higher expression of SIRT1 induced resistance of esophageal squamous cell carcinoma cells to cisplatin[J].J Thora Dis,2015,7(4):711-719.DOI:0.3978/j.issn.2072-1439.2015.04.01.
2017, Vol. 26 
